✨ Education and Health Notices
3640 NEW ZEALAND GAZETTE No. 145
by the Minister of Education, I hereby extend the closing
date for receiving nominations and all subsequent actions,
in accordance with the Education (School Trustee
Elections) Regulations 2000, for the election of the student
representative for the Awatapu College Board of Trustees.
The closing date for voting will be 1 November 2001.
This notice takes effect the day after its notification in the
New Zealand Gazette.
Dated at Wellington this 16th day of October 2001.
KATHY PHILLIPS, Senior Manager, National Operations.
go7406
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new medicines set out in the Schedule hereto:
Schedule
Product:
Bupafen epidural infusion
Active Ingredient(s):
Bupivacaine hydrochloride (monohydrate) 1.319mg/mL equivalent to 1.25mg/mL bupivacaine
hydrochloride anhydrous
Fentanyl citrate 3.144µg/mL equivalent to 2.0 µg/mL fentanyl
Dosage Form:
Solution for infusion
New Zealand Sponsor:
Biomed Limited
Manufacturer(s):
Biomed Limited, Point Chevalier, Auckland
Product:
DeWorm
Active Ingredient(s):
Mebendazole 100mg
Dosage Form:
Chewable tablet
New Zealand Sponsor:
Multichem Laboratories Limited
Manufacturer(s):
Cipla Limited, Manufacturing Division, Kurkumbh Village, Taluka - Daund, District - Pune
(Maharashtra), India
Product:
Invanz
Active Ingredient(s):
Ertapenem sodium 209.2mg/mL equivalent to 200mg/mL ertapenem free acid
Dosage Form:
Powder for injection
New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s):
Laboratoires Merck Sharp & Dohme - Chibret, (Mirabel Plant), Clermont-Ferrand, France
Product:
Starlix
Active Ingredient(s):
Nateglinide 120mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Novartis Pharma Stein AG/SA, Stein, Switzerland
Product:
Starlix
Active Ingredient(s):
Nateglinide 180mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Novartis Pharma Stein AG/SA, Stein, Switzerland
Product:
Starlix
Active Ingredient(s):
Nateglinide 60mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer(s):
Novartis Pharma Stein AG/SA, Stein, Switzerland
Product:
Viratac
Active Ingredient(s):
Aciclovir 5%w/w
Dosage Form:
Topical cream
New Zealand Sponsor:
Multichem Laboratories Limited
Manufacturer(s):
Cipla Limited, Manufacturing Division, Patalganga, District Raigad, (Maharashtra), India
Dated this 16th day of October 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of
February 1997).
go7447
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 145
Gazette.govt.nz —
NZ Gazette 2001, No 145
✨ LLM interpretation of page content
🎓
Extension of Closing Date for Student Representative Election
(continued from previous page)
🎓 Education, Culture & Science16 October 2001
Education, School Trustee Elections, Awatapu College, Wellington
- Kathy Phillips, Senior Manager, National Operations
🏥 Consent to Distribution of New Medicines
🏥 Health & Social Welfare16 October 2001
Medicines Act, New Medicines, Distribution Consent, Health
- G. R. Boyd, Chief Advisor, Safety and Regulation